Abstract

This study investigated the inhibitory effect and mechanism of curcumol on growth of human hepatocellular carcinoma (HCC) HepG2 xenografts in nude mice. Curcumol was isolated from from zedoary turmeric oil. The HepG2 xenograft model in nude mice was established. Forty modeled nude mice were divided into model, cisplatin, curcumol and cisplatin+curcumol groups. The latter three groups were treated with 2 mg/kg cisplatin, 100 mg/kg curcumol and 2 mg/kg cisplatin combined with 100 mg/kg curcumol, respectively, once every two days, for total seven times. After treatment, compared with cisplatin group, in cisplatin+curcumol group the tumor weight and tumor inhibition rate were obviously increased, the apoptosis rate of HepG2 cells was obviously increased, the expression levels of Caspase-3 and B-cell lymphoma-2 associated X proteins in xenograft tumor were significantly increased, and the expression level of B-cell lymphoma-2 protein was significantly decreased. In addition, the thymus index and spleen index of animal had no significant difference between cisplatin group and cisplatin+curcumol group. In conclusion, the additional use of curcumol can obviously increase the inhibitory effect of cisplatin on growth of HCC HepG2 xenografts in nude mice. The mechanism may be related to the enhanced promotion of apoptosis of tumor.

Highlights

  • Hepatocellular carcinoma (HCC) is one of the most common malignant tumors

  • Practical Application: This study has provided an experimental basis for the clinical application of curcumol to cancer therapy

  • After two weeks of treatment, the tumor weight and tumor inhibition rate in cisplatin+curcumol group was obviously lower than that in cisplatin group, respectively. This indicates that, curcumol can obviously increase the inhibitory effect of cisplatin on growth of HCC HepG2 xenografts in nude mice

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. It has the characteristics of occult onset, rapid progress, high malignancy, short survival, difficult treatment and poor prognosis (Tangkijvanich et al, 2000). Chemotherapy is one of the main methods for the treatment of HCC. The traditional chemotherapy drugs can kill the cancer cells, and damage the normal cells in different degrees, which seriously affects the patients’ compliance and treatment effect. HCC is generally resistant and insensitive to chemotherapy drugs (Thomas, 2009). With the progress of molecular biology and chemical separation technology, the experimental study of natural drugs in the treatment of HCC has become a research hotspot of tumor therapy (Wu & Xie, 2008; Rawat et al, 2018)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call